Difference Between Crohn’s and Ulcerative Colitis

While both Crohn’s disease and ulcerative colitis fall under inflammatory bowel disease (IBD), they differ fundamentally in where inflammation occurs, how deeply tissue damage penetrates, and which symptoms dominate your daily life. Crohn’s can attack anywhere from mouth to anus and burrows through all intestinal layers, while ulcerative colitis restricts itself to the colon’s innermost lining. Understanding these distinctions determines not only your diagnosis but also which natural interventions like targeted herbal formulations can deliver genuine remission rather than temporary symptom masking.

Quick Answer: The Core Distinctions That Define Each Condition

Living with inflammatory bowel disease means understanding exactly what’s happening inside your body. The difference between Crohn’s and ulcerative colitis isn’t just academic it shapes every treatment decision you make. According to Medicaldaily, about 4.1 million adults in the United States have been diagnosed with IBD, and knowing which form you have determines your path forward.

The two conditions share the “IBD” label, but they behave very differently. Crohn’s disease is a whole-digestive-tract condition that can appear anywhere from your mouth to your anus. Ulcerative colitis stays put in your colon and rectum. That location difference matters enormously for inflammatory bowel disease fundamentals because it affects which treatments can actually reach the inflamed tissue.

@keyframes hoox-lf-in-hoox-f-9f5445e5-efbc-42ee-bc41-e23863-top {
from { opacity: 0; transform: translateY(8px); }
to { opacity: 1; transform: translateY(0); }
}

#hoox-f-9f5445e5-efbc-42ee-bc41-e23863-top {
width: 100%;
max-width: 100%;
box-sizing: border-box;
display: flex;
flex-direction: column;
gap: 20px;
margin: 48px 0;
padding: 32px 28px;
border-radius: 16px;
background: #ffffff;
color: #111111;
font-family: inherit;
border: 1px solid #E2E8F0;
animation: hoox-lf-in-hoox-f-9f5445e5-efbc-42ee-bc41-e23863-top 0.3s cubic-bezier(0.16, 1, 0.3, 1);
direction: inherit;
}

#hoox-f-9f5445e5-efbc-42ee-bc41-e23863-top .hoox-form-header {
display: flex;
flex-direction: column;
gap: 8px;
text-align: center;
}

#hoox-f-9f5445e5-efbc-42ee-bc41-e23863-top .hoox-form-header h2 {
margin: 0;
font-size: 1.5em;
font-weight: 700;
line-height: 1.3;
color: #111111;
border: none;
padding: 0;
}

#hoox-f-9f5445e5-efbc-42ee-bc41-e23863-top .hoox-form-header p {
margin: 0;
font-size: 1em;
line-height: 1.6;
color: #64748B;
}

#hoox-f-9f5445e5-efbc-42ee-bc41-e23863-top form[data-hx-form] {
margin: 0;
display: flex;
flex-direction: column;
gap: 14px;
}

#hoox-f-9f5445e5-efbc-42ee-bc41-e23863-top .hoox-field-wrap {
position: relative;
width: 100%;
box-sizing: border-box;
}

#hoox-f-9f5445e5-efbc-42ee-bc41-e23863-top .hoox-field-wrap input {
width: 100%;
box-sizing: border-box;
height: 44px;
padding-inline-start: 42px;
padding-inline-end: 14px;
border: 1px solid #E2E8F0;
border-radius: 10px;
font-size: 14px;
color: #111111;
font-family: inherit;
background-color: #F8FAFC;
transition: border-color 0.15s ease, box-shadow 0.15s ease, background-color 0.15s ease;
outline: none;
direction: inherit;
text-align: start;
}

#hoox-f-9f5445e5-efbc-42ee-bc41-e23863-top .hoox-field-wrap input::placeholder {
color: #94A3B8;
opacity: 1;
}

#hoox-f-9f5445e5-efbc-42ee-bc41-e23863-top .hoox-field-wrap input:focus {
background-color: #FFFFFF;
border-color: #0077B6,#00B4D8,#90E0EF;
box-shadow: 0 0 0 3px rgba(15, 23, 42, 0.08);
}

#hoox-f-9f5445e5-efbc-42ee-bc41-e23863-top .hoox-field-icon {
position: absolute;
top: 0;
bottom: 0;
inset-inline-start: 0;
width: 42px;
display: flex;
align-items: center;
justify-content: center;
pointer-events: none;
color: #94A3B8;
transition: color 0.15s ease;
}

#hoox-f-9f5445e5-efbc-42ee-bc41-e23863-top .hoox-field-wrap:focus-within .hoox-field-icon {
color: #0077B6,#00B4D8,#90E0EF;
}

#hoox-f-9f5445e5-efbc-42ee-bc41-e23863-top button[type=”submit”] {
width: 100%;
height: 44px;
margin-top: 4px;
border: none;
border-radius: 10px;
background: #0077B6,#00B4D8,#90E0EF;
color: #FFFFFF;
font-size: 14px;
font-weight: 600;
cursor: pointer;
transition: opacity 0.15s ease, transform 0.15s ease, box-shadow 0.15s ease;
box-shadow: 0 1px 2px 0 rgba(0, 0, 0, 0.05);
}

#hoox-f-9f5445e5-efbc-42ee-bc41-e23863-top button[type=”submit”]:hover {
opacity: 0.94;
}

#hoox-f-9f5445e5-efbc-42ee-bc41-e23863-top button[type=”submit”]:active {
transform: scale(0.99);
}

#hoox-f-9f5445e5-efbc-42ee-bc41-e23863-top button[type=”submit”]:disabled {
opacity: 0.6;
cursor: not-allowed;
}

#hoox-f-9f5445e5-efbc-42ee-bc41-e23863-top .hoox-disclaimer {
margin: 0;
text-align: center;
font-size: 12px;
line-height: 1.5;
color: #94A3B8;
}

#hoox-f-9f5445e5-efbc-42ee-bc41-e23863-top .hoox-disclaimer a {
color: inherit;
text-decoration: underline;
text-underline-offset: 2px;
}

#hoox-f-9f5445e5-efbc-42ee-bc41-e23863-top .hoox-disclaimer a:hover {
text-decoration: none;
}

#hoox-f-9f5445e5-efbc-42ee-bc41-e23863-top .hoox-success {
display: none;
flex-direction: column;
align-items: center;
gap: 14px;
padding: 12px 0;
position: relative;
}

#hoox-f-9f5445e5-efbc-42ee-bc41-e23863-top .hoox-confetti {
position: absolute;
inset: 0;
overflow: visible;
pointer-events: none;
}

#hoox-f-9f5445e5-efbc-42ee-bc41-e23863-top .hoox-confetti span {
position: absolute;
top: 50%;
left: 50%;
width: 7px;
height: 11px;
background: var(–hoox-c);
border-radius: 2px;
opacity: 0;
animation: hoox-confetti-burst 0.9s ease-out forwards;
animation-delay: var(–hoox-d, 0s);
}

@keyframes hoox-confetti-burst {
0% { opacity: 1; transform: translate(-50%, -50%) rotate(0deg) scale(1); }
100% { opacity: 0; transform: translate(calc(-50% + var(–hoox-tx)), calc(-50% + var(–hoox-ty))) rotate(var(–hoox-rz)) scale(0.5); }
}

#hoox-f-9f5445e5-efbc-42ee-bc41-e23863-top .hoox-success-icon {
width: 52px;
height: 52px;
border-radius: 50%;
background: #ECFDF5;
display: flex;
align-items: center;
justify-content: center;
font-size: 26px;
line-height: 1;
animation: hoox-success-pop 0.4s cubic-bezier(0.34, 1.56, 0.64, 1);
}

@keyframes hoox-success-pop {
from { opacity: 0; transform: scale(0.5); }
to { opacity: 1; transform: scale(1); }
}

#hoox-f-9f5445e5-efbc-42ee-bc41-e23863-top .hoox-success-text {
margin: 0;
text-align: center;
font-size: 15px;
font-weight: 600;
line-height: 1.5;
color: #111111;
}

#hoox-f-9f5445e5-efbc-42ee-bc41-e23863-top .hoox-disabled-state {
display: none;
flex-direction: column;
align-items: center;
gap: 14px;
padding: 12px 0;
text-align: center;
}

#hoox-f-9f5445e5-efbc-42ee-bc41-e23863-top .hoox-disabled-icon {
width: 52px;
height: 52px;
border-radius: 50%;
background: #F1F5F9;
display: flex;
align-items: center;
justify-content: center;
color: #64748B;
}

#hoox-f-9f5445e5-efbc-42ee-bc41-e23863-top .hoox-disabled-text {
margin: 0;
font-size: 14px;
line-height: 1.6;
color: #64748B;
}

#hoox-f-9f5445e5-efbc-42ee-bc41-e23863-top .hoox-disabled-text a {
color: inherit;
font-weight: 600;
text-decoration: underline;
text-underline-offset: 2px;
}

#hoox-f-9f5445e5-efbc-42ee-bc41-e23863-top .hoox-disabled-text a:hover {
text-decoration: none;
}

Think of it this way: Crohn’s is the deep-diver of IBD, tunneling through every tissue layer and causing structural damage that creates holes and narrowings. Colitis stays on the surface, causing intense inflammation but rarely burrowing through the wall. This depth distinction explains why Crohn’s patients face more surgical interventions they develop complications that medications alone cannot resolve.

Where Inflammation Strikes: Anatomical Location Patterns [2026 Data]

Crohn’s disease doesn’t follow rules. It can skip entire sections of healthy intestine and attack somewhere else entirely. Doctors call these “skip lesions” patchy areas of inflammation with normal tissue in between. This unpredictable pattern makes diagnosis harder and treatment more complex because you’re never quite sure where inflammation will appear next.

Ulcerative colitis plays by different rules. It starts in the rectum and works its way backward through the colon in a continuous stretch. No skipping, no gaps. The inflammation spreads as a single patch that extends however far it’s going to go. This predictable pattern actually helps with diagnosis and means targeted IBD solutions can focus treatment directly on the colon.

• Crohn’s Locations: Mouth (oral ulcers), esophagus, stomach, small intestine (most common site), large intestine, anus (fissures and fistulas)
• Crohn’s Locations: Any segment of the 30-foot digestive tract
• Crohn’s Locations: Ileocecal valve junction (where small meets large intestine)
• Crohn’s Locations: Perianal region (causing significant external complications)
• Ulcerative Colitis Location: Colon and rectum only nowhere else
• Ulcerative Colitis Location: Continuous inflammation starting from rectum

This location difference explains why certain interventions work better for colitis. Herbal formulations that coat and soothe the colon lining have a direct target with ulcerative colitis. Crohn’s inflammation might be hiding in the small intestine where topical treatments can’t easily reach. According to Nih, a multinational cohort study involving over a million patients with IBD across seven countries revealed significant differences in disease trajectories based on geographical location and treatment approaches.

For patients researching digestive inflammation options, understanding your specific disease location matters enormously. A product formulated for colitis patients targets the colon directly which is exactly where colitis lives. Crohn’s patients need systemic approaches that can reach the entire digestive tract, or they need their disease to be primarily colon-based to benefit from colon-targeted therapies.

Tissue Penetration Depth: Why Crohn’s Creates Fistulas While Colitis Doesn’t

Here’s where the comparison gets serious. Crohn’s disease is transmural it burns through all layers of the intestinal wall. The mucosa, submucosa, muscle layers, and outer serosa all become targets. This deep penetration creates tunnels between intestinal segments or between the intestine and other organs. These abnormal connections are called fistulas, and they’re uniquely a Crohn’s complication because ulcerative colitis simply doesn’t penetrate deeply enough to create them.

Ulcerative colitis stays on the surface specifically, the mucosal layer. That innermost lining becomes inflamed, ulcerated, and bloody, but the disease respects the boundary. It doesn’t tunnel. It doesn’t create holes. This limitation actually protects colitis patients from developing fistulas, though they face their own set of serious complications including the risk of colon cancer after prolonged inflammation.

This depth difference has treatment implications that many patients don’t realize. herbal approach to deep inflammation must reach all tissue layers to benefit Crohn’s patients fully. Surface-level treatments enemas, topical applicators work beautifully for colitis because the disease lives on the surface. Crohn’s patients often need oral systemic treatments that can deliver anti-inflammatory compounds throughout the digestive tract and into deeper tissue layers.

Crohn’s transmural inflammation explains why approximately 50% of patients require surgery within 10 years of diagnosis deep tissue damage creates complications that medications cannot reverse, including bowel obstructions from scar tissue and abscesses from bacterial invasion through intestinal perforations.

The abscess risk in Crohn’s comes directly from this penetrating inflammation. When the intestinal wall develops small holes, bacteria that normally live inside your gut escape into the abdominal cavity. The immune system walls them off, creating pockets of infection that require drainage and antibiotics. Colitis doesn’t cause these abscesses because the intestinal wall remains intact despite the inflammation.

The Complication Profile: Strictures, Perforations, and Surgical Intervention Rates

Crohn’s leaves scars. Every episode of deep inflammation heals with fibrosis thickened, non-functional tissue that narrows the intestinal opening. These strictures can eventually block food passage entirely, requiring surgical intervention. The chronic inflammation also increases cancer risk in the affected areas, though this risk is lower than with extensive ulcerative colitis.

Ulcerative colitis complications cluster differently. patient experiences with disease complications show that while colitis patients don’t typically develop fistulas or strictures, they face a distinct set of risks. After eight to ten years of continuous inflammation, colon cancer surveillance becomes essential. The inflamed tissue becomes dysplastic, creating precancerous changes that require careful monitoring or preventive surgery.

• Crohn’s Complications: Intestinal strictures causing bowel obstruction
• Crohn’s Complications: Fistulas connecting intestine to bladder, skin, or vagina
• Crohn’s Complications: Intra-abdominal abscesses requiring drainage
• Crohn’s Complications: Malnutrition from malabsorption in damaged small intestine
• Crohn’s Complications: Perianal disease including fissures and abscesses

• Colitis Complications: Severe bleeding episodes requiring transfusion
• Colitis Complications: Toxic megacolon (life-threatening colon dilation)
• Colitis Complications: Colon cancer risk after prolonged disease duration
• Colitis Complications: Primary sclerosing cholangitis (bile duct inflammation)
• Colitis Complications: Osteoporosis from chronic inflammation and steroid use

Symptom Presentation: Bleeding Patterns, Pain Location, and Daily Impact

Living with IBD means learning your symptom language. Crohn’s patients often describe a gnawing, cramping pain in the lower right abdomen near the ileocecal valve where small intestine meets large. The pain often correlates with eating, because food moving through narrowed intestinal segments triggers discomfort. Weight loss happens frequently, not just from appetite loss but from actual malabsorption of nutrients.

Ulcerative colitis tells a different story. understanding your IBD symptoms starts with recognizing that bloody diarrhea is the hallmark. The rectal bleeding is prominent, visible, and often alarming. Patients describe urgency the sensation of needing to reach a bathroom immediately which comes from rectal inflammation that disrupts normal storage function. According to Cdc, about 4.1 million adults in the United States have been diagnosed with IBD, and symptom recognition remains the critical first step toward proper treatment.

Patients with ulcerative colitis often report bowel movement frequencies exceeding 10-15 per day during flares, with nighttime urgency that prevents continuous sleep a pattern less common in Crohn’s disease where symptoms often relate more to eating than to bowel frequency alone.

How Diagnosis Differs: Endoscopy Findings and Biopsy Markers

Getting diagnosed correctly requires different approaches for each condition. Crohn’s disease can hide in the small intestine beyond a standard colonoscope’s reach. You might need capsule endoscopy a tiny camera you swallow or balloon-assisted enteroscopy to visualize the middle sections of your digestive tract. The inflammation pattern showing skip lesions with healthy tissue in between strongly suggests Crohn’s.

Ulcerative colitis shows up clearly on standard colonoscopy because the disease lives within the colon’s reach. The inflammation looks continuous, starting in the rectum and extending however far upward it goes. The mucosa appears friable easily bleeding when touched and shows superficial ulceration patterns distinct from the deep, linear ulcers seen in Crohn’s.

• Colonoscopy: Primary tool for ulcerative colitis; shows continuous colonic inflammation pattern
• Upper Endoscopy (EGD): Required for Crohn’s when upper GI symptoms present
• capsule Endoscopy: Visualizes small intestine for hidden Crohn’s inflammation
• MRI/CT Enterography: Identifies Crohn’s strictures and fistulas not visible endoscopically

our diagnostic journey understanding

Biopsy samples taken during endoscopy provide the definitive answer. Pathologists look for granulomas clusters of immune cells that appear in about 30% of Crohn’s cases but never in ulcerative colitis. Their presence confirms Crohn’s diagnosis even when symptoms seem ambiguous. The absence of granulomas doesn’t rule out Crohn’s, but their presence rules in the diagnosis conclusively.

Treatment Response Patterns: Why Natural TNF-α Blockers Target Each Condition Differently

Mainstream medicine approaches both conditions with similar drug classes anti-inflammatories, immunomodulators, and biologics. But the limitations become apparent when you examine remission rates. Conventional medications often suppress symptoms without healing the underlying inflammation. Patients cycle through options, experiencing temporary relief followed by treatment failure.

Natural anti-inflammatory approaches work differently. natural remission solutions using targeted herbal formulations can address the inflammatory cascade at its source particularly the tumor necrosis factor alpha (TNF-α) pathway that drives both conditions. These compounds work by modulating the immune response rather than completely suppressing it, potentially offering remission without the infection risks of biological drugs.

The four-herb formulation from Kronlitis addresses colon-based inflammation specifically. For ulcerative colitis patients, this targeted approach makes intuitive sense the herbs reach exactly where the disease lives. Crohn’s patients benefit when their disease primarily affects the colon, which is common enough that many Crohn’s diagnoses actually specify “Crohn’s colitis” to indicate colon-predominant disease.

Understanding the difference between Crohn’s and ulcerative colitis means understanding why a colon-focused herbal approach works brilliantly for one condition and works selectively for the other. When Crohn’s confines itself to the colon, the same interventions that help colitis patients can deliver meaningful remission.

Key Takeaways: Matching Your IBD Type to Effective Management

Getting your diagnosis right isn’t semantics it’s survival. The difference between Crohn’s and ulcerative colitis shapes every aspect of your treatment journey, from medication choices to surgical timing to natural intervention selection. Understanding these distinctions empowers you to advocate for appropriate care.

• Confirm your location: Know whether your inflammation is colonic only (favoring targeted approaches) or diffuse (requiring systemic treatment)
• Understand your tissue depth: Transmural disease (Crohn’s) carries different risks than mucosal disease (colitis)
• Monitor for condition-specific complications: Fistulas in Crohn’s, dysplasia surveillance in long-standing colitis
• Match treatment to anatomy: Colon-focused herbal formulations benefit both conditions when disease is colon-based
• Define remission realistically: Aim for mucosal healing and normal bowel function, not just symptom reduction

explore colon-focused IBD products

Remission is possible. Whether through conventional medications, natural interventions, or combined approaches, patients with both Crohn’s and ulcerative colitis achieve genuine symptom control and return to normal life. The key is matching your treatment to your specific disease type because the difference between these conditions isn’t just diagnostic, it’s deeply practical.

Frequently Asked Questions About Crohn’s vs Ulcerative Colitis

Can you have both Crohn’s disease and ulcerative colitis simultaneously?

No these are distinct diagnoses that cannot coexist in the same patient. The conditions represent different manifestations of inflammatory bowel disease, and diagnosis requires meeting specific criteria for one or the other. However, some patients receive an “IBD-unclassified” diagnosis when features of both conditions appear, representing about 10-15% of IBD cases where clear categorization isn’t immediately possible. This indeterminate colitis often clarifies over time as the disease pattern reveals itself through symptoms and testing.

Which condition is more severe, Crohn’s or ulcerative colitis?

Neither is universally more severe severity depends on disease extent and individual factors. Crohn’s creates more structural complications like fistulas and strictures requiring surgery, while ulcerative colitis carries higher cancer risk after prolonged disease duration. About 70-80% of Crohn’s patients require surgery within their lifetime compared to 30-40% of colitis patients. Individual disease course varies dramatically in both conditions, making generalized severity comparisons misleading.

Do Crohn’s and ulcerative colitis symptoms overlap significantly?

Yes significant overlap exists in core symptoms including diarrhea, abdominal pain, fatigue, and weight loss. The overlap reaches approximately 60-70% in symptom presentation, which explains why diagnostic testing proves essential. However, distinguishing features like prominent rectal bleeding (colitis), perianal disease (Crohn’s), and pain location patterns help direct appropriate testing. Symptom overlap means you cannot diagnose either condition from symptoms alone endoscopy and biopsy remain essential.

Can diet alone reverse Crohn’s disease or ulcerative colitis?

No no diet can cure or reverse inflammatory bowel disease, though dietary modifications significantly impact symptom management. Specific diets like exclusive enteral nutrition achieve remission in some Crohn’s cases, particularly pediatric patients, with remission rates reaching 60-80% in children. However, dietary intervention works best as part of comprehensive treatment, not in isolation. Eliminating trigger foods reduces symptom burden and improves quality of life but doesn’t address the underlying inflammatory process.

When do natural remedies work best for IBD management?

Natural interventions work best when inflammation is active but hasn’t created irreversible structural damage. Herbal anti-inflammatories like those targeting the TNF-α pathway similar to biological drugs but from plant sources show promise in early disease or mild-to-moderate flares. Patients who haven’t yet developed complications like strictures or dysplasia often respond best. The four-herb approach addressing colon inflammation specifically helps both ulcerative colitis patients and Crohn’s patients with colon-predominant disease achieve meaningful remission.

What defines true remission in inflammatory bowel disease?

True remission means mucosal healing endoscopic proof that the intestinal lining has healed, not just symptom resolution. Clinical remission (feeling well) differs from endoscopic remission (looking well), and achieving both defines genuine disease control. Patients with endoscopic remission have dramatically lower complication rates and hospitalization risk compared to those with symptom control alone. Remission rates with optimal treatment reach 40-60% for colitis and 30-50% for Crohn’s disease when using comprehensive approaches including natural anti-inflammatory interventions.

@keyframes hoox-lf-in-hoox-f-9f5445e5-efbc-42ee-bc41-e23863-bottom {
from { opacity: 0; transform: translateY(8px); }
to { opacity: 1; transform: translateY(0); }
}

#hoox-f-9f5445e5-efbc-42ee-bc41-e23863-bottom {
width: 100%;
max-width: 100%;
box-sizing: border-box;
display: flex;
flex-direction: column;
gap: 20px;
margin: 48px 0;
padding: 32px 28px;
border-radius: 16px;
background: #ffffff;
color: #111111;
font-family: inherit;
border: 1px solid #E2E8F0;
animation: hoox-lf-in-hoox-f-9f5445e5-efbc-42ee-bc41-e23863-bottom 0.3s cubic-bezier(0.16, 1, 0.3, 1);
direction: inherit;
}

#hoox-f-9f5445e5-efbc-42ee-bc41-e23863-bottom .hoox-form-header {
display: flex;
flex-direction: column;
gap: 8px;
text-align: center;
}

#hoox-f-9f5445e5-efbc-42ee-bc41-e23863-bottom .hoox-form-header h2 {
margin: 0;
font-size: 1.5em;
font-weight: 700;
line-height: 1.3;
color: #111111;
border: none;
padding: 0;
}

#hoox-f-9f5445e5-efbc-42ee-bc41-e23863-bottom .hoox-form-header p {
margin: 0;
font-size: 1em;
line-height: 1.6;
color: #64748B;
}

#hoox-f-9f5445e5-efbc-42ee-bc41-e23863-bottom form[data-hx-form] {
margin: 0;
display: flex;
flex-direction: column;
gap: 14px;
}

#hoox-f-9f5445e5-efbc-42ee-bc41-e23863-bottom .hoox-field-wrap {
position: relative;
width: 100%;
box-sizing: border-box;
}

#hoox-f-9f5445e5-efbc-42ee-bc41-e23863-bottom .hoox-field-wrap input {
width: 100%;
box-sizing: border-box;
height: 44px;
padding-inline-start: 42px;
padding-inline-end: 14px;
border: 1px solid #E2E8F0;
border-radius: 10px;
font-size: 14px;
color: #111111;
font-family: inherit;
background-color: #F8FAFC;
transition: border-color 0.15s ease, box-shadow 0.15s ease, background-color 0.15s ease;
outline: none;
direction: inherit;
text-align: start;
}

#hoox-f-9f5445e5-efbc-42ee-bc41-e23863-bottom .hoox-field-wrap input::placeholder {
color: #94A3B8;
opacity: 1;
}

#hoox-f-9f5445e5-efbc-42ee-bc41-e23863-bottom .hoox-field-wrap input:focus {
background-color: #FFFFFF;
border-color: #0077B6,#00B4D8,#90E0EF;
box-shadow: 0 0 0 3px rgba(15, 23, 42, 0.08);
}

#hoox-f-9f5445e5-efbc-42ee-bc41-e23863-bottom .hoox-field-icon {
position: absolute;
top: 0;
bottom: 0;
inset-inline-start: 0;
width: 42px;
display: flex;
align-items: center;
justify-content: center;
pointer-events: none;
color: #94A3B8;
transition: color 0.15s ease;
}

#hoox-f-9f5445e5-efbc-42ee-bc41-e23863-bottom .hoox-field-wrap:focus-within .hoox-field-icon {
color: #0077B6,#00B4D8,#90E0EF;
}

#hoox-f-9f5445e5-efbc-42ee-bc41-e23863-bottom button[type=”submit”] {
width: 100%;
height: 44px;
margin-top: 4px;
border: none;
border-radius: 10px;
background: #0077B6,#00B4D8,#90E0EF;
color: #FFFFFF;
font-size: 14px;
font-weight: 600;
cursor: pointer;
transition: opacity 0.15s ease, transform 0.15s ease, box-shadow 0.15s ease;
box-shadow: 0 1px 2px 0 rgba(0, 0, 0, 0.05);
}

#hoox-f-9f5445e5-efbc-42ee-bc41-e23863-bottom button[type=”submit”]:hover {
opacity: 0.94;
}

#hoox-f-9f5445e5-efbc-42ee-bc41-e23863-bottom button[type=”submit”]:active {
transform: scale(0.99);
}

#hoox-f-9f5445e5-efbc-42ee-bc41-e23863-bottom button[type=”submit”]:disabled {
opacity: 0.6;
cursor: not-allowed;
}

#hoox-f-9f5445e5-efbc-42ee-bc41-e23863-bottom .hoox-disclaimer {
margin: 0;
text-align: center;
font-size: 12px;
line-height: 1.5;
color: #94A3B8;
}

#hoox-f-9f5445e5-efbc-42ee-bc41-e23863-bottom .hoox-disclaimer a {
color: inherit;
text-decoration: underline;
text-underline-offset: 2px;
}

#hoox-f-9f5445e5-efbc-42ee-bc41-e23863-bottom .hoox-disclaimer a:hover {
text-decoration: none;
}

#hoox-f-9f5445e5-efbc-42ee-bc41-e23863-bottom .hoox-success {
display: none;
flex-direction: column;
align-items: center;
gap: 14px;
padding: 12px 0;
position: relative;
}

#hoox-f-9f5445e5-efbc-42ee-bc41-e23863-bottom .hoox-confetti {
position: absolute;
inset: 0;
overflow: visible;
pointer-events: none;
}

#hoox-f-9f5445e5-efbc-42ee-bc41-e23863-bottom .hoox-confetti span {
position: absolute;
top: 50%;
left: 50%;
width: 7px;
height: 11px;
background: var(–hoox-c);
border-radius: 2px;
opacity: 0;
animation: hoox-confetti-burst 0.9s ease-out forwards;
animation-delay: var(–hoox-d, 0s);
}

@keyframes hoox-confetti-burst {
0% { opacity: 1; transform: translate(-50%, -50%) rotate(0deg) scale(1); }
100% { opacity: 0; transform: translate(calc(-50% + var(–hoox-tx)), calc(-50% + var(–hoox-ty))) rotate(var(–hoox-rz)) scale(0.5); }
}

#hoox-f-9f5445e5-efbc-42ee-bc41-e23863-bottom .hoox-success-icon {
width: 52px;
height: 52px;
border-radius: 50%;
background: #ECFDF5;
display: flex;
align-items: center;
justify-content: center;
font-size: 26px;
line-height: 1;
animation: hoox-success-pop 0.4s cubic-bezier(0.34, 1.56, 0.64, 1);
}

@keyframes hoox-success-pop {
from { opacity: 0; transform: scale(0.5); }
to { opacity: 1; transform: scale(1); }
}

#hoox-f-9f5445e5-efbc-42ee-bc41-e23863-bottom .hoox-success-text {
margin: 0;
text-align: center;
font-size: 15px;
font-weight: 600;
line-height: 1.5;
color: #111111;
}

#hoox-f-9f5445e5-efbc-42ee-bc41-e23863-bottom .hoox-disabled-state {
display: none;
flex-direction: column;
align-items: center;
gap: 14px;
padding: 12px 0;
text-align: center;
}

#hoox-f-9f5445e5-efbc-42ee-bc41-e23863-bottom .hoox-disabled-icon {
width: 52px;
height: 52px;
border-radius: 50%;
background: #F1F5F9;
display: flex;
align-items: center;
justify-content: center;
color: #64748B;
}

#hoox-f-9f5445e5-efbc-42ee-bc41-e23863-bottom .hoox-disabled-text {
margin: 0;
font-size: 14px;
line-height: 1.6;
color: #64748B;
}

#hoox-f-9f5445e5-efbc-42ee-bc41-e23863-bottom .hoox-disabled-text a {
color: inherit;
font-weight: 600;
text-decoration: underline;
text-underline-offset: 2px;
}

#hoox-f-9f5445e5-efbc-42ee-bc41-e23863-bottom .hoox-disabled-text a:hover {
text-decoration: none;
}

Cookie Privacy

To provide the best experiences, we use cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent may adversely affect certain features and functions.

Functional Functional Always active

Preferences Preferences

Statistics Statistics

Marketing Marketing

• Manage options
• Manage services
• Manage {vendor_count} vendors
• Read more about these purposes

Accept Deny View preferences Save preferences View preferences

• {title}
• {title}
• {title}